Newly released research suggests that levels of antibodies against the coronavirus have declined across the UK population since testing began. Having randomly sampled 365,000 people across the country, the React2 study—which is yet to be peer reviewed—estimates that 6% of the UK population had antibodies against the virus in late June, but that this had […]
U.S. Daily COVID-19 Case Count Sets New Record for the Pandemic
SATURDAY, Oct. 24, 2020 — The United States broke a bleak record on Friday, logging the highest daily number of new coronavirus cases since the pandemic began. The tally of over 80,000 new infections eclipses the previous record of 76,533 new cases set on July 17, during a surge in cases across the Sun Belt, […]
New tool predicts risks of hospital admission and death from COVID-19
A new risk tool, developed by UK researchers to predict a person’s risk of being admitted to hospital and dying from COVID-19 has been published by The BMJ today. With cases increasing in the UK and elsewhere, and winter approaching, there is an urgent need for reliable models that predict the likely course of COVID-19, […]
New vaccine could help halt Alzheimer’s progression, preclinical study finds
Our immune system’s capacity to mount a well-regulated defense against foreign substances, including toxins, weakens with age and makes vaccines less effective in people over age 65. At the same time, research has shown that immunotherapy targeting neurotoxic forms of the peptide amyloid beta (oligomeric Aβ) may halt the progression of Alzheimer’s disease, the most […]
Treatment for inflammatory bowel disease doesn’t always work; new study uncovers why
Inflammatory bowel disease (IBD) affects more than 70,000 children in the United States and the prevalence is rising. In fact, 25% of the 3.1 million individuals with IBD present before 21 years of age. There is no cure for IBD, and treatment often includes medication to block a molecule that causes inflammation in the intestines […]
New lab test clarifies the potential protective effects of COVID-19 antibodies
Knowing you have developed antibodies against the SARS-CoV-2 virus after recovering from COVID-19 doesn’t tell you everything about your immunity. The levels and even types of antibodies can differ among patients, and those differences can influence whether a person is protected against being reinfected. Scientists at The Ohio State University have developed a new lab […]
New study highlights the role of risk communication in coping with COVID-19
The mental effects of pandemics on people can arise not only from the burden of preventive measures, the fear of contracting and cure but also coping with the exponential deaths. It was predicted in 2018 that the next major outbreak and its containment challenges might not be due to a lack of preventive technologies, but […]
Molly Sims’ New No-Diet Ab-Blasting Secret
Slim and svelte! For the first time ever, there’s a machine that uses radio frequency heating to burn fat cells plus electromagnetic waves to contract muscles for sculpting and celebs — including Molly Sims, Jenny McCarthy and Carmen Electra — have already tested the technology! Say hello to EmSculpt Neo. No One Will Know These […]
This Canadian Woman Just Set a New World Record by Planking for 4 Hours Like It's NBD?
Four minutes of planking sounds extreme to most people (time goes much slower when you’re holding your body above the ground, right?), but Canadian athlete Dana Glowacka isn’t like most people—and her version of extreme planking lasts a little longer. Four hours, 19 minutes, and 55 seconds to be precise, which was long enough to […]
Genomic study of 6000 NCI-MATCH cancer patients leads to new clinical trial benchmarks
Five years ago, the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and National Cancer Institute (NCI), part of the National Institutes of Health, jointly launched a very different kind of cancer study. NCI-Molecular Analysis for Therapy Choice (NCI-MATCH or EAY131), the largest precision medicine cancer trial to date, sought to match genetic abnormalities driving patients’ tumors with […]